SLQT

SELECTQUOTE INC

Financial Services | Small Cap

-$0.18

EPS Forecast

$283.3

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2024-12-31
EX-99.1 2 selectquoteincmarch312023pr.htm EX-99.1 Document
Exhibit 99.1
SelectQuote, Inc. Reports Third Quarter of Fiscal Year 2023 Results

Third Quarter of Fiscal Year 2023 – Consolidated Earnings Highlights

•Revenue of $299.4 million
•Net income of $9.3 million
•Adjusted EBITDA* of $44.0 million

Updating Fiscal Year 2023 Guidance Ranges:

•Revenue now expected in a range of $950 million to $970 million
•Net loss now expected in a range of $68 million to $48 million
•Adjusted EBITDA* now expected in a range of $40 million to $50 million

Third Quarter of Fiscal Year 2023 – Segment Highlights

Senior
•Revenue of $185.2 million
•Adjusted EBITDA* of $59.2 million
•Approved Medicare Advantage policies of 165,530

Healthcare Services
•Revenue of $70.7 million
•Adjusted EBITDA* of $(3.4) million
•Approximately 45,000 SelectRx members

Life
•Revenue of $37.0 million
•Adjusted EBITDA* of $5.3 million

Auto & Home
•Revenue of $8.2 million
•Adjusted EBITDA* of $2.6 million

OVERLAND PARK, Kan., May 10, 2023--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the third quarter of fiscal year 2023 of $299.4 million compared to consolidated revenue for the third quarter of fiscal year 2022 of $274.3 million. Consolidated net income for the third quarter of fiscal year 2023 was $9.3 million compared to consolidated net loss for the third quarter of fiscal year 2022 of $7.0 million. Finally, consolidated Adjusted EBITDA* for the third quarter of fiscal year 2023 was $44.0 million compared to consolidated Adjusted EBITDA* for the third quarter of fiscal year 2022 of $12.2 million.

SelectQuote Chief Executive Officer, Tim Danker, added, “Our strong results for the third quarter are an ongoing function of our strategic redesign and the continued scale of our Healthcare Services segment. None of this would be possible without the hard work of our operational teams and importantly, SelectQuote’s talented workforce. We are proud of our achievements over the past five quarters and firmly believe our results validate our strategy to drive more predictable profit and cash flow. Specifically, in Senior, our continued gains in agent productivity, costs per policy and policyholder persistency drove margin and cash flow that were inline with previous peak results, despite increased conservatism in booked lifetime values per policy. More importantly, we believe the demonstrated unit economics in Senior were achieved with substantially enhanced forecast visibility, which drove our out performance as we were able to scale volume in both AEP and OEP.”

“Our Healthcare Services business, headlined by SelectRx, also made meaningful progress toward scaled profitability, which we expect to accelerate as membership continues to onboard and season. SelectRx’s value continues to resonate with consumers, and SelectRx will increasingly benefit SelectQuote’s financial profile given its accelerated cash flow dynamics compared to Senior.”

*See “Non-GAAP Financial Measures” below.

Mr. Danker concluded, “Based on SelectQuote’s overall out performance year-to-date, we increased our guidance for fiscal year 2023 and have positioned the business very well as we plan for fiscal 2024.”

Segment Results

We currently report on four segments: 1) Senior, 2) Healthcare Services, 3) Life, and 4) Auto & Home. The performance measures of the segments include total revenue and Adjusted EBITDA.* Costs of revenue, cost of goods sold-pharmacy revenue, marketing and advertising, selling, general, and administrative, and technical development operating expenses that are directly attributable to a segment are reported within the applicable segment. Indirect costs of revenue, marketing and advertising, selling, general, and administrative, and technical development operating expenses are allocated to each segment based on varying metrics such as headcount. Adjusted EBITDA is calculated as total revenue for the applicable segment less direct and allocated costs of revenue, cost of goods sold, marketing and advertising, technical development, and selling, general, and administrative operating costs and expenses, excluding depreciation and amortization expense; gain or loss on disposal of property, equipment, and software; share-based compensation expense; and non-recurring expenses such as severance payments and transaction costs. Adjusted EBITDA Margin is calculated as Adjusted EBITDA divided by revenue.

Senior

Financial Results

The following table provides the financial results for the Senior segment for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
(in thousands)20232022% Change20232022% Change
Revenue$185,200 $210,973 (12)%$486,541 $459,272 6 %
Adjusted EBITDA*59,166 39,950 48 %138,933 (129,311)207 %
Adjusted EBITDA Margin*32 %19 %29 %(28)%

Operating Metrics

Submitted Policies

Submitted policies are counted when an individual completes an application with our licensed agent and provides authorization to the agent to submit the application to the insurance carrier partner. The applicant may have additional actions to take before the application will be reviewed by the insurance carrier.

The following table shows the number of submitted policies for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
20232022% Change20232022% Change
Medicare Advantage196,372 242,721 (19)%538,247 678,827 (21)%
Medicare Supplement675 1,389 (51)%2,905 6,318 (54)%
Dental, Vision and Hearing21,175 40,178 (47)%59,513 122,214 (51)%
Prescription Drug Plan416 1,079 (61)%2,082 6,193 (66)%
Other1,864 4,907 (62)%5,402 11,436 (53)%
Total220,502 290,274 (24)%608,149 824,988 (26)%



*See “Non-GAAP Financial Measures” below.
2

Approved Policies

Approved policies represents the number of submitted policies that were approved by our insurance carrier partners for the identified product during the indicated period. Not all approved policies will go in force.

The following table shows the number of approved policies for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
20232022% Change20232022% Change
Medicare Advantage165,530 196,377 (16)%467,540 546,031 (14)%
Medicare Supplement557 1,159 (52)%2,184 4,654 (53)%
Dental, Vision and Hearing16,968 34,486 (51)%47,940 101,251 (53)%
Prescription Drug Plan521 1,095 (52)%1,794 5,315 (66)%
Other1,029 3,836 (73)%3,932 9,199 (57)%
Total184,605 236,953 (22)%523,390 666,450 (21)%

Lifetime Value of Commissions per Approved Policy

Lifetime value of commissions per approved policy represents commissions estimated to be collected over the estimated life of an approved policy based on multiple factors, including but not limited to, contracted commission rates, carrier mix and expected policy persistency with applied constraints. The lifetime value of commissions per approved policy is equal to the sum of the commission revenue due upon the initial sale of a policy, and when applicable, an estimate of future renewal commissions.

The following table shows the lifetime value of commissions per approved policy for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
(dollars per policy):20232022% Change20232022% Change
Medicare Advantage$965 $933 3 %$888 $935 (5)%
Medicare Supplement871 949 (8)%994 1,275 (22)%
Dental, Vision and Hearing91 120 (24)%95 123 (23)%
Prescription Drug Plan194 229 (15)%211 235 (10)%
Other123 95 29 %100 77 30 %

Healthcare Services

Financial Results

The following table provides the financial results for the Healthcare Services segment for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
(in thousands)20232022% Change20232022% Change
Revenue$70,725 $23,123 206 %$169,270 $40,183 321 %
Adjusted EBITDA*(3,366)(7,768)57 %(24,456)(20,113)(22)%
Adjusted EBITDA Margin*(5)%(34)%(14)%(50)%




*See “Non-GAAP Financial Measures” below.
3

Operating Metrics

Members

The total number of SelectRx members represents the amount of active customers to which an order has been shipped, as this is the primary key driver of revenue for Healthcare Services.

The following table shows the total number of SelectRx members as of the periods presented:

March 31, 2023March 31, 2022
Total SelectRx Members44,99316,991

Combined Senior and Healthcare Services - Consumer Per Unit Economics

The opportunity to leverage our existing database and distribution model to improve access to healthcare services for our consumers has created a need for us to review our key metrics related to our per unit economics. As we think about the revenue and expenses for Healthcare Services, we note that they are derived from the marketing acquisition costs associated with the sale of an MA or MS policy, some of which costs are allocated directly to Healthcare Services, and therefore determined that our per unit economics measure should include components from both Senior and Healthcare Services. See details of revenue and expense items included in the calculation below.

Combined Senior and Healthcare Services consumer per unit economics represents total MA and MS commissions; other product commissions; other revenues, including revenues from Healthcare Services; and operating expenses associated with Senior and Healthcare Services, each shown per number of approved MA and MS policies over a given time period. Management assesses the business on a per-unit basis to help ensure that the revenue opportunity associated with a successful policy sale is attractive relative to the marketing acquisition cost. Because not all acquired leads result in a successful policy sale, all per-policy metrics are based on approved policies, which is the measure that triggers revenue recognition.

The MA and MS commission per MA/MS policy represents the LTV for policies sold in the period. Other commission per MA/MS policy represents the LTV for other products sold in the period, including DVH prescription drug plan, and other products, which management views as additional commission revenue on our agents’ core function of MA/MS policy sales. Pharmacy revenue per MA/MS policy represents revenue from SelectRx and other revenue per MA/MS policy represents revenue from Population Health, production bonuses, marketing development funds, lead generation revenue, and adjustments from the Company’s reassessment of its cohorts’ transaction prices. Total operating expenses per MA/MS policy represents all of the operating expenses within Senior and Healthcare Services. The revenue to customer acquisition cost (“CAC”) multiple represents total revenue per MA/MS policy as a multiple of total marketing acquisition cost, which represents the direct costs of acquiring leads. These costs are included in marketing and advertising expense within the total operating expenses per MA/MS policy.

The following table shows combined Senior and Healthcare Services consumer per unit economics for the periods presented. Based on the seasonality of Senior and the fluctuations between quarters, we believe that the most relevant view of per unit economics is on a rolling 12-month basis. All per MA/MS policy metrics below are based on the sum of approved MA/MS policies, as both products have similar commission profiles.












4

Twelve Months Ended March 31,
(dollars per approved policy):20232022
Medicare Advantage and Medicare Supplement approved policies586,238 636,195 
Medicare Advantage and Medicare Supplement commission per MA/MS policy$886 $963 
Other commission per MA/MS policy15 29 
Pharmacy revenue per MA/MS policy320 52 
Other revenue per MA/MS policy66 (64)
Total revenue per MA/MS policy1,287 980 
Total operating expenses per MA/MS policy(1,167)(1,176)
Adjusted EBITDA per MA/MS policy *$120 $(196)
Adjusted EBITDA Margin per MA/MS policy *9 %(20)%
Revenue/CAC multiple 3.5X  1.8X

Total revenue per MA/MS policy increased 31% for the twelve months ended March 31, 2023 compared to the twelve months ended March 31, 2022, primarily due to the increase in pharmacy revenue. Total operating expenses per MA/MS policy were nearly flat for the twelve months ended March 31, 2023 compared to the twelve months ended March 31, 2022, driven by a decrease in our marketing and advertising costs, which was offset by an increase in cost of goods sold-pharmacy revenue for Healthcare Services due to the growth of the business.

Life

Financial Results

The following table provides the financial results for the Life segment for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
(in thousands)20232022% Change20232022% Change
Revenue$36,950 $38,625 (4)%$107,780 $116,645 (8)%
Adjusted EBITDA*5,303 (2,662)299 %16,371 (701)2435 %
Adjusted EBITDA Margin*14 %(7)%15 %(1)%

Operating Metrics

Life premium represents the total premium value for all policies that were approved by the relevant insurance carrier partner and for which the policy document was sent to the policyholder and payment information was received by the relevant insurance carrier partner during the indicated period. Because our commissions are earned based on a percentage of total premium, total premium volume for a given period is the key driver of revenue for our Life segment.














*See “Non-GAAP Financial Measures” below.
5

The following table shows term and final expense premiums for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
(in thousands)20232022% Change20232022% Change
Term Premiums$17,528 $14,933 17 %$48,450 $45,990 5 %
Final Expense Premiums19,308 28,532 (32)%58,766 83,718 (30)%
Total$36,836 $43,465 (15)%107,216 129,708 (17)%

Auto & Home

Financial Results

The following table provides the financial results for the Auto & Home segment for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
(in thousands)20232022% Change20232022% Change
Revenue$8,238 $7,152 15 %$23,128 $20,755 11 %
Adjusted EBITDA*2,591 1,150 125 %7,315 3,957 85 %
Adjusted EBITDA Margin*31 %16 %32 %19 %

Operating Metrics

Auto & Home premium represents the total premium value of all new policies that were approved by our insurance carrier partners during the indicated period. Because our commissions are earned based on a percentage of total premium, total premium volume for a given period is the key driver of revenue for our Auto & Home segment.

The following table shows premiums for the periods presented:

Three Months Ended March 31,Nine Months Ended March 31,
(in thousands):20232022% Change20232022% Change
Premiums$12,828 $12,516 2 %$36,456 $36,358 — %



















*See “Non-GAAP Financial Measures” below.
6

Earnings Conference Call

SelectQuote, Inc. will host a conference call with the investment community tomorrow, Thursday, May 11, 2023, beginning at 8:30 a.m. ET. To register for this conference call, please use this link: https://www.netroadshow.com/events/login?show=830b3ad4&confId=49510A. After registering, a confirmation will be sent via email, including dial-in details and unique conference call codes for entry. Registration is open through the live call, but to ensure you are connected for the full call we suggest registering at least 10 minutes before the start of the call. The event will also be webcasted live via our investor relations website https://ir.selectquote.com/investor-home/default.aspx.

Non-GAAP Financial Measures

This release includes certain non-GAAP financial measures intended to supplement, not substitute for, comparable GAAP measures. To supplement our financial statements presented in accordance with GAAP and to provide investors with additional information regarding our GAAP financial results, we have presented in this release Adjusted EBITDA and Adjusted EBITDA Margin, which are non-GAAP financial measures. These non-GAAP financial measures are not based on any standardized methodology prescribed by GAAP and are not necessarily comparable to similarly titled measures presented by other companies. We define Adjusted EBITDA as net income (loss) before interest expense, income tax expense (benefit), depreciation and amortization, and certain add-backs for non-cash or non-recurring expenses, including restructuring and share-based compensation expenses. The most directly comparable GAAP measure is net income (loss). We define Adjusted EBITDA Margin as Adjusted EBITDA divided by revenue. The most directly comparable GAAP measure is net income margin. We monitor and have presented in this release Adjusted EBITDA and Adjusted EBITDA Margin because they are key measures used by our management and Board of Directors to understand and evaluate our operating performance, to establish budgets, and to develop operational goals for managing our business. In particular, we believe that excluding the impact of these expenses in calculating Adjusted EBITDA can provide a useful measure for period-to-period comparisons of our core operating performance.

We believe that these non-GAAP financial measures help identify underlying trends in our business that could otherwise be masked by the effect of the expenses that we exclude in the calculations of these non-GAAP financial measures. Accordingly, we believe that these financial measures provide useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance and future prospects.

Reconciliations of net income (loss) to Adjusted EBITDA are presented below beginning on page 12.

Forward Looking Statements

This release contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as “may,” “should,” “could,” “predict,” “potential,” “believe,” “will likely result,” “expect,” “continue,” “will,” “anticipate,” “seek,” “estimate,” “intend,” “plan,” “projection,” “would” and “outlook,” or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements.
 
There are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the following: the ultimate duration and impact of the ongoing COVID-19 pandemic and any other public health events, our reliance on a limited number of insurance carrier partners and any potential termination of those relationships or failure to develop new relationships; existing and future laws and regulations affecting the health insurance market; changes in health insurance products offered by our insurance carrier partners and the health insurance market generally; insurance carriers offering products and services directly to consumers; changes to commissions paid by insurance carriers and
7

underwriting practices; competition with brokers, including exclusively online brokers and carriers who opt to sell policies directly to consumers; competition from government-run health insurance exchanges; developments in the U.S. health insurance system; our dependence on revenue from carriers in our senior segment and downturns in the senior health as well as life, automotive and home insurance industries; our ability to develop new offerings and penetrate new vertical markets; risks from third-party products; failure to enroll individuals during the Medicare annual enrollment period; our ability to attract, integrate and retain qualified personnel; our dependence on lead providers and ability to compete for leads; failure to obtain and/or convert sales leads to actual sales of insurance policies; access to data from consumers and insurance carriers; accuracy of information provided from and to consumers during the insurance shopping process; cost-effective advertisement through internet search engines; ability to contact consumers and market products by telephone; global economic conditions, including inflation; disruption to operations as a result of future acquisitions; significant estimates and assumptions in the preparation of our financial statements; impairment of goodwill; potential litigation and other legal proceedings or inquiries; our existing and future indebtedness; our ability to maintain compliance with our debt covenants; access to additional capital; failure to protect our intellectual property and our brand; fluctuations in our financial results caused by seasonality; accuracy and timeliness of commissions reports from insurance carriers; timing of insurance carriers’ approval and payment practices; factors that impact our estimate of the constrained lifetime value of commissions per policyholder; changes in accounting rules, tax legislation and other legislation; disruptions or failures of our technological infrastructure and platform; failure to maintain relationships with third-party service providers; cybersecurity breaches or other attacks involving our systems or those of our insurance carrier partners or third-party service providers; our ability to protect consumer information and other data; and failure to market and sell Medicare plans effectively or in compliance with laws. For a further discussion of these and other risk factors that could impact our future results and performance, see the section entitled “Risk Factors” in the most recent Annual Report on Form 10-K (the “Annual Report”) and subsequent periodic reports filed by us with the Securities and Exchange Commission. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

About SelectQuote:

Founded in 1985, SelectQuote (NYSE: SLQT) provides solutions that help consumers protect their most valuable assets: their families, health, and property. The company pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote’s success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads.

With an ecosystem offering high touchpoints for consumers across Insurance, Medicare, Pharmacy, and Value-Based Care, the company now has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote Senior serves the needs of a demographic that sees around 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. SelectQuote Healthcare Services is comprised of the SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with best-in-class healthcare services that fit each member's unique healthcare needs. The platform improves health outcomes and lowers healthcare costs through proactive engagement and access to high-value healthcare solutions.

Investor Relations:
Sloan Bohlen
877-678-4083
investorrelations@selectquote.com

Media:
Matt Gunter
913-286-4931
matt.gunter@selectquote.com

Source: SelectQuote, Inc.
8


SELECTQUOTE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands)

March 31, 2023June 30, 2022
ASSETS
CURRENT ASSETS:
Cash and cash equivalents$92,048 $140,997 
Accounts receivable, net of allowances of $2.2 million and $0.6 million, respectively211,686 129,748 
Commissions receivable-current68,531 116,277 
Other current assets11,504 15,751 
Total current assets383,769 402,773 
COMMISSIONS RECEIVABLE—Net753,003 722,349 
PROPERTY AND EQUIPMENT—Net31,601 41,804 
SOFTWARE—Net16,127 16,301 
OPERATING LEASE RIGHT-OF-USE ASSETS26,312 28,016 
INTANGIBLE ASSETS—Net27,019 31,255 
GOODWILL29,136 29,136 
OTHER ASSETS20,989 18,418 
TOTAL ASSETS$1,287,956 $1,290,052 
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable$31,608 $24,766 
Accrued expenses23,162 26,002 
Accrued compensation and benefits49,087 42,150 
Operating lease liabilities—current5,958 5,261 
Current portion of long-term debt25,412 7,169 
Contract liabilities9,717 3,404 
Other current liabilities1,580 4,761 
Total current liabilities146,524 113,513 
LONG-TERM DEBT, NET—less current portion667,306 698,423 
DEFERRED INCOME TAXES49,134 50,080 
OPERATING LEASE LIABILITIES30,329 33,946 
OTHER LIABILITIES3,244 2,985 
Total liabilities896,537 898,947 
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY:
Common stock, $0.01 par value1,667 1,644 
Additional paid-in capital564,484 554,845 
Accumulated deficit(187,806)(177,100)
Accumulated other comprehensive income13,074 11,716 
Total shareholders’ equity391,419 391,105 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY$1,287,956 $1,290,052 
9

SELECTQUOTE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
(In thousands)

Three Months Ended March 31,Nine Months Ended March 31,
2023202220232022
REVENUE:
Commission$197,258 $221,764 $533,627 $492,528 
Pharmacy66,948 18,478 159,641 31,715 
Other35,192 34,097 87,802 100,412 
Total revenue299,398 274,339 781,070 624,655 
OPERATING COSTS AND EXPENSES:
Cost of revenue79,186 96,491 235,827 319,469 
Cost of goods sold—pharmacy revenue62,302 19,294 154,753 34,338 
Marketing and advertising90,205 125,082 237,724 409,005 
Selling, general, and administrative27,544 24,705 86,662 70,495 
Technical development6,434 6,436 18,860 18,675 
Total operating costs and expenses265,671 272,008 733,826 851,982 
INCOME (LOSS) FROM OPERATIONS33,727 2,331 47,244 (227,327)
INTEREST EXPENSE, NET(21,105)(12,179)(58,885)(31,300)
OTHER INCOME (EXPENSE), NET(206)(23)(118)(177)
INCOME (LOSS) BEFORE INCOME TAX EXPENSE (BENEFIT)12,416 (9,871)(11,759)(258,804)
INCOME TAX EXPENSE (BENEFIT)3,152 (2,846)(1,053)(65,984)
NET INCOME (LOSS)$9,264 $(7,025)$(10,706)$(192,820)
NET INCOME (LOSS) PER SHARE:
Basic$0.06 $(0.04)$(0.06)$(1.17)
Diluted$0.06 $(0.04)$(0.06)$(1.17)
WEIGHTED-AVERAGE COMMON STOCK OUTSTANDING USED IN PER SHARE AMOUNTS:
Basic166,543 164,083 165,951 163,914 
Diluted167,905 164,083 165,951 163,914 
OTHER COMPREHENSIVE INCOME (LOSS) NET OF TAX:
Gain (loss) on cash flow hedge(2,661)7,589 1,358 9,358 
OTHER COMPREHENSIVE INCOME (LOSS)(2,661)7,589 1,358 9,358 
COMPREHENSIVE INCOME (LOSS)$6,603 $564 $(9,348)$(183,462)
10

SELECTQUOTE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)

Nine Months Ended March 31,
20232022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss$(10,706)$(192,820)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Depreciation and amortization21,087 17,957 
Loss on disposal of property, equipment, and software390 741 
Share-based compensation expense8,525 6,252 
Deferred income taxes(1,416)(66,378)
Amortization of debt issuance costs and debt discount6,250 4,217 
Write-off of debt issuance costs710 — 
Accrued interest payable in kind8,450 — 
Non-cash lease expense3,115 3,065 
Changes in operating assets and liabilities:
Accounts receivable, net(62,738)(59,837)
Commissions receivable17,092 7,601 
Other assets3,166 (8,275)
Accounts payable and accrued expenses6,440 8,096 
Operating lease liabilities(4,331)(3,868)
Other liabilities(8,869)(1,113)
Net cash used in operating activities(12,835)(284,362)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment(1,056)(24,515)
Purchases of software and capitalized software development costs(5,804)(7,570)
Acquisition of business— (6,927)
Investment in equity securities— (1,000)
Net cash used in investing activities(6,860)(40,012)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Revolving Credit Facility— 50,000 
Payments on Revolving Credit Facility— (50,000)
Proceeds from Term Loans— 242,000 
Payments on Term Loans(17,833)(1,793)
Payments on other debt(123)(130)
Proceeds from common stock options exercised and employee stock purchase plan1,187 3,179 
Payments of tax withholdings related to net share settlement of equity awards(40)(148)
Payments of debt issuance costs(10,110)(328)
Payment of acquisition holdback(2,335)(5,501)
Net cash (used in) provided by financing activities(29,254)237,279 
NET DECREASE IN CASH AND CASH EQUIVALENTS(48,949)(87,095)
CASH AND CASH EQUIVALENTS—Beginning of period140,997 286,454 
CASH AND CASH EQUIVALENTS—End of period$92,048 $199,359 

11

SELECTQUOTE, INC. AND SUBSIDIARIES
Net Income (Loss) to Adjusted EBITDA Reconciliation
(Unaudited)

Three Months Ended March 31, 2023
(in thousands)SeniorHealthcare ServicesLifeAuto & HomeCorp & ElimsConsolidated
Revenue$185,200 $70,725 $36,950 $8,238 $(1,715)$299,398 
Operating expenses(126,034)(74,091)(31,446)(5,648)(17,947)(255,166)
Other income (expense), net— — (201)1 (6)(206)
Adjusted EBITDA59,166 (3,366)5,303 2,591 (19,668)44,026 
Share-based compensation expense(2,959)
Non-recurring expenses(433)
Depreciation and amortization(7,098)
Loss on disposal of property, equipment, and software(15)
Interest expense, net(21,105)
Income tax expense(3,152)
Net income$9,264 


Three Months Ended March 31, 2022
(in thousands)SeniorHealthcare ServicesLifeAuto & HomeCorp & ElimsConsolidated
Revenue$210,973 $23,123 $38,625 $7,152 $(5,534)$274,339 
Operating expenses(171,023)(30,891)(41,287)(6,002)(12,896)(262,099)
Other expenses, net— — — — (23)(23)
Adjusted EBITDA39,950 (7,768)(2,662)1,150 (18,453)12,217 
Share-based compensation expense(2,143)
Non-recurring expenses(703)
Depreciation and amortization(6,679)
Loss on disposal of property, equipment, and software(384)
Interest expense, net(12,179)
Income tax benefit2,846 
Net loss$(7,025)

12

Nine Months Ended March 31, 2023
(in thousands)SeniorHealthcare ServicesLifeAuto & HomeCorp & ElimsConsolidated
Revenue$486,541 $169,270 $107,780 $23,128 $(5,649)$781,070 
Operating expenses(347,608)(193,726)(91,409)(15,812)(52,270)(700,825)
Other expenses, net— — — (1)(117)(118)
Adjusted EBITDA138,933 (24,456)16,371 7,315 (58,036)80,127 
Share-based compensation expense(8,525)
Transaction costs(3,003)
Depreciation and amortization(21,087)
Loss on disposal of property, equipment, and software(386)
Interest expense, net(58,885)
Income tax benefit1,053 
Net loss$(10,706)


Nine Months Ended March 31, 2022
(in thousands)SeniorHealthcare ServicesLifeAuto & HomeCorp & ElimsConsolidated
Revenue$459,272 $40,183 $116,645 $20,755 $(12,200)$624,655 
Operating expenses(588,583)(60,296)(117,346)(16,798)(41,154)(824,177)
Other expenses, net— — — — (177)(177)
Adjusted EBITDA(129,311)(20,113)(701)3,957 (53,531)(199,699)
Share-based compensation expense(6,252)
Non-recurring expenses(2,857)
Depreciation and amortization(17,957)
Loss on disposal of property, equipment, and software(739)
Interest expense, net(31,300)
Income tax benefit65,984 
Net loss$(192,820)








13

SELECTQUOTE, INC. AND SUBSIDIARIES
Net Loss to Adjusted EBITDA Reconciliation
(Unaudited)



Guidance net loss to Adjusted EBITDA reconciliation, year ending June 30, 2023:

(in thousands)Range
Net loss$(68,000)$(48,000)
Income tax benefit$(20,000)$(16,000)
Interest expense, net$74,000 $74,000 
Depreciation and amortization$24,000 $24,000 
Share-based compensation expense$12,000 $12,000 
Transaction costs$18,000 $4,000 
Adjusted EBITDA$40,000 $50,000 



14